The Hippo pathway in cardiac fibrosis: mechanisms and therapeutic prospects

Area of Science:

• Cardiovascular Research
• Molecular Biology
• Cell Signaling

Background:

• Cardiac fibrosis, characterized by excessive extracellular matrix deposition, is a hallmark of advanced cardiovascular diseases like heart failure and myocardial infarction.
• Abnormal cardiac fibroblast activation drives fibrosis, leading to impaired myocardial compliance and cardiac dysfunction.
• The Hippo signaling pathway is an evolutionarily conserved kinase cascade crucial for organ development and tissue homeostasis, with emerging roles in cardiac fibrosis.

Purpose of the Study:

• To systematically review the molecular mechanisms of Hippo signaling in cardiac fibrosis.
• To emphasize the cell type-specific regulatory functions of the Hippo pathway in the heart.
• To explore therapeutic strategies targeting the Hippo pathway for cardiac fibrosis.

Main Methods:

• Systematic literature review.
• Analysis of molecular mechanisms.
• Examination of cell-specific roles in cardiomyocytes, fibroblasts, and immune cells.
• Review of pathway cross-talk and disease stage-dependent effects.

Main Results:

• The Hippo pathway significantly influences cardiac fibrosis through cell-specific mechanisms.
• Its role varies across different cardiac cell types, disease types, and progression stages.
• Complex cross-talk with other signaling pathways modulates fibrotic responses.

Conclusions:

• The Hippo signaling pathway is a critical regulator of cardiac fibrosis with cell-dependent functions.
• Targeting the Hippo pathway presents a promising avenue for novel anti-fibrotic therapies.
• Further research into pathway interactions and disease context is essential for therapeutic development.